ResMed Inc. (0KW4.L)
USD 233.41
(-3.67%)
USD 233.41
(-3.67%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 873.93 Million USD | -44.68% |
| 2023 | 1.57 Billion USD | 72.19% |
| 2022 | 917.55 Million USD | 15.6% |
| 2021 | 793.71 Million USD | -38.91% |
| 2020 | 1.29 Billion USD | 2.24% |
| 2019 | 1.27 Billion USD | 351.53% |
| 2018 | 281.45 Million USD | -73.91% |
| 2017 | 1.07 Billion USD | -8.2% |
| 2016 | 1.17 Billion USD | 290.89% |
| 2015 | 300.59 Million USD | -0.06% |
| 2014 | 300.78 Million USD | 0.0% |
| 2013 | 300.78 Million USD | 19.91% |
| 2012 | 250.83 Million USD | 150.43% |
| 2011 | 100.16 Million USD | -17.69% |
| 2010 | 121.68 Million USD | -24.76% |
| 2009 | 161.73 Million USD | 17.49% |
| 2008 | 137.65 Million USD | 18.67% |
| 2007 | 115.99 Million USD | -4.2% |
| 2006 | 121.08 Million USD | -30.56% |
| 2005 | 174.36 Million USD | 53.97% |
| 2004 | 113.25 Million USD | 0.0% |
| 2003 | 113.25 Million USD | -8.11% |
| 2002 | 123.25 Million USD | -17.83% |
| 2001 | 150 Million USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | -100.0% |
| 1998 | 200 Thousand USD | -66.67% |
| 1997 | 600 Thousand USD | -33.33% |
| 1996 | 900 Thousand USD | 12.5% |
| 1995 | 800 Thousand USD | 100.0% |
| 1994 | 400 Thousand USD | 33.33% |
| 1993 | 300 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 FY | 873.93 Million USD | -44.68% |
| 2024 Q1 | 1.49 Billion USD | -5.33% |
| 2024 Q2 | 1.39 Billion USD | -6.97% |
| 2024 Q4 | 873.93 Million USD | -25.14% |
| 2024 Q3 | 1.16 Billion USD | -16.09% |
| 2023 Q3 | 1.72 Billion USD | -11.11% |
| 2023 FY | 1.57 Billion USD | 72.19% |
| 2023 Q1 | 930.63 Million USD | 1.43% |
| 2023 Q2 | 1.93 Billion USD | 108.4% |
| 2023 Q4 | 1.57 Billion USD | -8.36% |
| 2022 Q3 | 832.08 Million USD | -0.57% |
| 2022 Q1 | 950.1 Million USD | 19.7% |
| 2022 Q2 | 836.86 Million USD | -11.92% |
| 2022 FY | 917.55 Million USD | 15.6% |
| 2022 Q4 | 917.55 Million USD | 10.27% |
| 2021 Q1 | 1.18 Billion USD | -8.49% |
| 2021 FY | 793.71 Million USD | -38.91% |
| 2021 Q2 | 965.8 Million USD | -18.77% |
| 2021 Q3 | 868.8 Million USD | -10.04% |
| 2021 Q4 | 793.71 Million USD | -8.64% |
| 2020 FY | 1.29 Billion USD | 2.24% |
| 2020 Q2 | 1.39 Billion USD | 7.15% |
| 2020 Q3 | 1.5 Billion USD | 7.71% |
| 2020 Q4 | 1.29 Billion USD | -13.78% |
| 2020 Q1 | 1.3 Billion USD | 2.73% |
| 2019 Q1 | 529.61 Million USD | 88.17% |
| 2019 Q3 | 1.33 Billion USD | 11.54% |
| 2019 Q2 | 1.19 Billion USD | 126.1% |
| 2019 Q4 | 1.27 Billion USD | -4.85% |
| 2019 FY | 1.27 Billion USD | 351.53% |
| 2018 Q1 | 1.01 Billion USD | -5.54% |
| 2018 Q4 | 281.45 Million USD | -65.25% |
| 2018 Q3 | 810 Million USD | -20.52% |
| 2018 FY | 281.45 Million USD | -73.91% |
| 2018 Q2 | 1.01 Billion USD | 0.03% |
| 2017 Q2 | 1.16 Billion USD | -0.4% |
| 2017 Q1 | 1.17 Billion USD | -0.16% |
| 2017 Q4 | 1.07 Billion USD | -7.68% |
| 2017 FY | 1.07 Billion USD | -8.2% |
| 2017 Q3 | 1.16 Billion USD | -0.01% |
| 2016 Q4 | 1.17 Billion USD | 169.74% |
| 2016 FY | 1.17 Billion USD | 290.89% |
| 2016 Q2 | 401.57 Million USD | -19.78% |
| 2016 Q1 | 500.58 Million USD | 66.53% |
| 2016 Q3 | 435.6 Million USD | 8.47% |
| 2015 Q1 | 375.7 Million USD | 24.91% |
| 2015 FY | 300.59 Million USD | -0.06% |
| 2015 Q2 | 449.66 Million USD | 19.69% |
| 2015 Q3 | 460.58 Million USD | 2.43% |
| 2015 Q4 | 300.59 Million USD | -34.74% |
| 2014 FY | 300.78 Million USD | 0.0% |
| 2014 Q1 | 360.8 Million USD | 19.96% |
| 2014 Q3 | 395.8 Million USD | -9.18% |
| 2014 Q4 | 300.78 Million USD | -24.01% |
| 2014 Q2 | 435.81 Million USD | 20.79% |
| 2013 Q2 | 300.85 Million USD | 13.17% |
| 2013 Q1 | 265.83 Million USD | 5.98% |
| 2013 Q4 | 300.78 Million USD | -11.75% |
| 2013 FY | 300.78 Million USD | 19.91% |
| 2013 Q3 | 340.81 Million USD | 13.28% |
| 2012 Q3 | 235.98 Million USD | 4.21% |
| 2012 Q4 | 250.83 Million USD | 6.29% |
| 2012 Q2 | 226.45 Million USD | 68.87% |
| 2012 FY | 250.83 Million USD | 150.43% |
| 2012 Q1 | 134.09 Million USD | 33.88% |
| 2011 FY | 100.16 Million USD | -17.69% |
| 2011 Q2 | 64.35 Million USD | -31.39% |
| 2011 Q3 | 80.23 Million USD | 24.67% |
| 2011 Q4 | 100.16 Million USD | 24.84% |
| 2011 Q1 | 93.8 Million USD | -22.92% |
| 2010 FY | 121.68 Million USD | -24.76% |
| 2010 Q2 | 145.12 Million USD | -11.18% |
| 2010 Q1 | 163.38 Million USD | 1.02% |
| 2010 Q3 | 143.69 Million USD | -0.98% |
| 2010 Q4 | 121.68 Million USD | -15.32% |
| 2009 Q4 | 161.73 Million USD | 1.35% |
| 2009 FY | 161.73 Million USD | 17.49% |
| 2009 Q3 | 159.58 Million USD | 4.37% |
| 2009 Q2 | 152.9 Million USD | 5.36% |
| 2009 Q1 | 145.12 Million USD | 5.43% |
| 2008 Q4 | 137.65 Million USD | 4.12% |
| 2008 Q2 | 132.62 Million USD | 14.42% |
| 2008 Q1 | 115.91 Million USD | -0.07% |
| 2008 FY | 137.65 Million USD | 18.67% |
| 2008 Q3 | 132.2 Million USD | -0.32% |
| 2007 Q4 | 115.99 Million USD | 1.25% |
| 2007 FY | 115.99 Million USD | -4.2% |
| 2007 Q3 | 114.57 Million USD | -14.21% |
| 2007 Q2 | 133.54 Million USD | 11.0% |
| 2007 Q1 | 120.3 Million USD | -0.64% |
| 2006 Q2 | 203.58 Million USD | 10.34% |
| 2006 Q3 | 96.47 Million USD | -52.61% |
| 2006 Q4 | 121.08 Million USD | 25.51% |
| 2006 FY | 121.08 Million USD | -30.56% |
| 2006 Q1 | 184.5 Million USD | 5.81% |
| 2005 Q4 | 174.36 Million USD | 53.97% |
| 2005 Q3 | 113.25 Million USD | 0.0% |
| 2005 Q2 | 113.25 Million USD | 0.0% |
| 2005 Q1 | 113.25 Million USD | 0.0% |
| 2005 FY | 174.36 Million USD | 53.97% |
| 2004 FY | 113.25 Million USD | 0.0% |
| 2004 Q4 | 113.25 Million USD | 0.0% |
| 2004 Q3 | 113.25 Million USD | -2.23% |
| 2004 Q2 | 115.82 Million USD | 2.28% |
| 2004 Q1 | 113.25 Million USD | 0.0% |
| 2003 Q3 | 113.25 Million USD | 0.0% |
| 2003 FY | 113.25 Million USD | -8.11% |
| 2003 Q2 | 113.25 Million USD | -4.23% |
| 2003 Q1 | 118.25 Million USD | -4.06% |
| 2003 Q4 | 113.25 Million USD | 0.0% |
| 2002 Q2 | 180 Million USD | 0.0% |
| 2002 Q3 | 146 Million USD | -18.89% |
| 2002 Q4 | 123.25 Million USD | -15.58% |
| 2002 FY | 123.25 Million USD | -17.83% |
| 2002 Q1 | 180 Million USD | 20.0% |
| 2001 Q2 | 4.5 Million USD | -35.71% |
| 2001 Q1 | 7 Million USD | 0.0% |
| 2001 FY | 150 Million USD | 0.0% |
| 2001 Q4 | 150 Million USD | 98.87% |
| 2001 Q3 | 75.42 Million USD | 1576.16% |
| 2000 Q2 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 1999 Q3 | 100 Thousand USD | 0.0% |
| 1999 FY | - USD | -100.0% |
| 1999 Q1 | 200 Thousand USD | 0.0% |
| 1999 Q2 | 100 Thousand USD | -50.0% |
| 1999 Q4 | - USD | -100.0% |
| 1998 Q4 | 200 Thousand USD | -33.33% |
| 1998 FY | 200 Thousand USD | -66.67% |
| 1998 Q2 | 400 Thousand USD | -33.33% |
| 1998 Q3 | 300 Thousand USD | -25.0% |
| 1998 Q1 | 600 Thousand USD | 0.0% |
| 1997 Q3 | 700 Thousand USD | 0.0% |
| 1997 FY | 600 Thousand USD | -33.33% |
| 1997 Q1 | 900 Thousand USD | 0.0% |
| 1997 Q2 | 700 Thousand USD | -22.22% |
| 1997 Q4 | 600 Thousand USD | -14.29% |
| 1996 FY | 900 Thousand USD | 12.5% |
| 1996 Q3 | 900 Thousand USD | 0.0% |
| 1996 Q4 | 900 Thousand USD | 0.0% |
| 1995 FY | 800 Thousand USD | 100.0% |
| 1995 Q4 | 800 Thousand USD | 0.0% |
| 1994 FY | 400 Thousand USD | 33.33% |
| 1994 Q4 | 400 Thousand USD | 0.0% |
| 1993 Q4 | 300 Thousand USD | 0.0% |
| 1993 FY | 300 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Phreesia, Inc. | 11.98 Million USD | -7193.124% |
| Accuray Incorporated | 172.15 Million USD | -407.641% |
| Align Technology, Inc. | 96.96 Million USD | -801.261% |
| Elevance Health Inc. | 25.12 Billion USD | 96.521% |
| AxoGen, Inc. | 69.29 Million USD | -1161.235% |
| Boston Scientific Corporation | 9.09 Billion USD | 90.393% |
| CVS Health Corporation | 79.38 Billion USD | 98.899% |
| Cardinal Health, Inc. | 5.6 Billion USD | 84.419% |
| Centene Corporation | 17.69 Billion USD | 95.062% |
| DaVita Inc. | 11.11 Billion USD | 92.138% |
| HCA Healthcare, Inc. | 41.85 Billion USD | 97.912% |
| Hologic, Inc. | 2.53 Billion USD | 65.52% |
| Humana Inc. | 10.21 Billion USD | 91.443% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | 7.801% |
| Laboratory Corporation of America Holdings | 5.95 Billion USD | 85.322% |
| Masimo Corporation | 970 Million USD | 9.904% |
| McKesson Corporation | 5.47 Billion USD | 84.029% |
| Patterson Companies, Inc. | 762.94 Million USD | -14.548% |
| Quest Diagnostics Incorporated | 5.36 Billion USD | 83.723% |
| Henry Schein, Inc. | 2.74 Billion USD | 68.116% |
| Teladoc Health, Inc. | 1.59 Billion USD | 45.114% |
| Universal Health Services, Inc. | 5.36 Billion USD | 83.715% |
| Veeva Systems Inc. | 55.77 Million USD | -1466.894% |
| Baxter International Inc. | 14.36 Billion USD | 93.916% |
| Becton, Dickinson and Company | 15.87 Billion USD | 94.496% |
| Intuitive Surgical, Inc. | 89.8 Million USD | -873.202% |
| Danaher Corporation | 19.35 Billion USD | 95.485% |
| Stryker Corporation | 12.99 Billion USD | 93.275% |
| Medtronic plc | 24.96 Billion USD | 96.499% |